• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cadernos de Saúde Pública >Desafios para promover o uso racional de drogas psicotrópicasDesafíos para promover el uso racional de drogas psicotrópicas
【24h】

Desafios para promover o uso racional de drogas psicotrópicasDesafíos para promover el uso racional de drogas psicotrópicas

机译：促进或合理使用精神药物的挑战促进合理使用精神药物的挑战

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Recently, an article entitled Adverse Drug Events Identified in Hospitalized Patients in Brazil by Interna tional Classification of Diseases (ICD-10) Code Listings was published in CSP 1. This study examined the potential of applying ICD-10 codes to a national database of the public health care system (Hospital Information Systems of the Brazilian Unified National Health Syustem – SIH-SUS) to contribute to learning about adverse drug events (ADEs) in hospitalized patients. The study stated that 14 out of 20 most frequent ADEs were identified in codes relating to mental disorders. This result study encour ages us to contribute to the debate pertaining the prescription of psychotropic drugs, illustrating the concern upon this type of prescription, which turned into an epidemic in the Brazil and has been a challenge for all regulatory agencies around the world. First, in some countries such as Brazil, the safe and effective use of psychopharmaceuticals needs revision by health professionals and university researchers. Second, prescription of psychoactive drugs should be based on the principles of Inte grative and Complementary Practices 2. Third, the electronic health records (EHRs) in psychiatric care should be adopted and improved. Although the EHRs represent a key component of the health care redesign, they do not meet all the needs of the health care providers and rarely benefit patients using psychotropic drugs 3. Fourth, there is a lack of cohesion within health care providers focusing on patient safety. Joining knowledge and practices of distinct areas that compose the health team at the scientific and technical level is vital for a successful multidisciplinary work 4. In Brazil, the multidisciplinary work to provide care for patients with mental disorders, chemical dependence, and psychoactive drug use is the responsibility of the Psychosocial Care Centers (known by the Portu guese acronym CAPS) linked to the public health system. However, because of government funding shortage, the rational use of psychoactive drugs does not have adequate monitoring and control, since access to them may occur differently from that advocated by the policies 5. In this sense, all regulatory agencies will have major challenges in identifying and developing practices to stimulate the rational use of psychotropic drugs.
机译：最近，在CSP 1中发表了一篇标题为《通过国际疾病分类在巴西住院患者中识别出的不良药物事件》（ICD-10）的文章。该研究探讨了将ICD-10编码应用于该国的国家数据库的潜力。公共卫生保健系统（巴西统一国家卫生系统医院信息系统– SIH-SUS），以有助于了解住院患者的药物不良事件（ADE）。该研究表明，在与精神障碍有关的法规中确定了20个最频繁的ADE中的14个。这项结果研究鼓励我们为与精神药物处方有关的辩论做出贡献，这说明了对这种处方的关注，这种关注在巴西已成为一种流行病，并且已成为全球所有监管机构的挑战。首先，在巴西等一些国家/地区，卫生专业人员和大学研究人员需要对安全有效使用心理药物进行修改。第二，精神药物的处方应基于综合和补充性实践的原则。2.第三，应采用和改善精神病医疗中的电子健康记录（EHR）。尽管EHR是重新设计医疗保健的关键组成部分，但它们并不能满足医疗保健提供者的所有需求，并且很少使使用精神药物的患者受益3。第四，医疗保健提供者在关注患者安全方面缺乏凝聚力。在科学和技术水平上将组成卫生团队的不同领域的知识和实践结合起来对于成功开展多学科工作至关重要。4.在巴西，为精神障碍，化学依赖和精神药物使用患者提供护理的多学科工作是至关重要的。与公共卫生系统相关的心理社会护理中心（Portu guese的缩写CAPS）的职责。但是，由于政府资金短缺，对精神药物的合理使用没有足够的监测和控制，因为获得精神药物的方式可能不同于政策所倡导的药物。5从这个意义上讲，所有监管机构在确定精神药物方面将面临重大挑战。并发展刺激合理使用精神药物的做法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号